These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 21134113)

  • 1. Apolipoprotein A-I deficiency does not affect biliary lipid secretion and gallstone formation in mice.
    Amigo L; Quiñones V; Leiva A; Busso D; Zanlungo S; Nervi F; Rigotti A
    Liver Int; 2011 Feb; 31(2):263-71. PubMed ID: 21134113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice.
    Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A
    Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD; Dietschy JM; Turley SD
    Hepatology; 2000 Dec; 32(6):1309-16. PubMed ID: 11093738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
    Moore RE; Kawashiri MA; Kitajima K; Secreto A; Millar JS; Pratico D; Rader DJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1914-20. PubMed ID: 12933536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular and clinical abnormalities of apolipoprotein A-I].
    Takada Y; Sasaki J
    Nihon Rinsho; 1994 Dec; 52(12):3246-52. PubMed ID: 7853718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
    Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
    Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein.
    Post SM; de Crom R; van Haperen R; van Tol A; Princen HM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):892-7. PubMed ID: 12649089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis.
    Jaimungal S; Wehmeier K; Mooradian AD; Haas MJ
    Nutr Res; 2011 Nov; 31(11):805-12. PubMed ID: 22118750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.
    Vaessen SF; Veldman RJ; Comijn EM; Snapper J; Sierts JA; van den Oever K; Beattie SG; Twisk J; Kuivenhoven JA
    J Gene Med; 2009 Aug; 11(8):697-707. PubMed ID: 19431216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apolipoprotein A-I mutations and low high density lipoproteinemia].
    Sasaki J
    Rinsho Byori; 1998 Jul; 46(7):684-8. PubMed ID: 9721536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.
    Fuchs M; Ivandic B; Müller O; Schalla C; Scheibner J; Bartsch P; Stange EF
    Hepatology; 2001 Jun; 33(6):1451-9. PubMed ID: 11391534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.
    Song W; Chen J; Redinger RN
    J Investig Med; 1998 Dec; 46(9):460-9. PubMed ID: 9861782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
    Xu G; Zhao L; Fuchs M
    Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical activity, biliary lipids, and gallstones in obese subjects.
    Chuang CZ; Martin LF; LeGardeur BY; Lopez A
    Am J Gastroenterol; 2001 Jun; 96(6):1860-5. PubMed ID: 11419840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic overexpression of caveolins increases bile salt secretion in mice.
    Moreno M; Molina H; Amigo L; Zanlungo S; Arrese M; Rigotti A; Miquel JF
    Hepatology; 2003 Dec; 38(6):1477-88. PubMed ID: 14647059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial apolipoprotein A-I variants].
    Matsunaga A
    Nihon Rinsho; 1999 Dec; 57(12):2795-800. PubMed ID: 10638215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apolipoprotein A-I deficiency].
    Moriyama K; Sasaki J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():281-4. PubMed ID: 11347076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.